Biotech companies by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 biotech companies ranked by P/B ratio, at 2.0, followed by Vaxcyte (3.5) and Neurocrine Biosciences (4.3). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen2.0
Median
9.1
Combined market value
£639B
Countries
5
Not ranked
6no P/B ratio on file

Market values as of .

All countries
All sectors
Biotech
GBP
Clear filters
Biotech companies by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care2.0£28.3B£191.63 0.53% up 49% up United States
2VaxcytePCVX · Health Care3.5£7.1B£44.63 1.15% down 22% up United States
3Neurocrine BiosciencesNBIX · Health Care4.3£12.6B£124.64 1.18% down 20% up United States
4RepligenRGEN · Health Care4.7£8.4B£131.80 6.92% up 5% up United States
5Bio-TechneTECH · Health Care5.3£8.7B£55.34 0.24% up 26% up United States
6Kymera TherapeuticsKYMR · Health Care6.5£7.9B£92.81 0.48% up 87% up United States
7Krystal BiotechKRYS · Health Care6.5£7.1B£239.68 5.62% up 46% up United States
8CG OncologyCGON · Health Care7.2£5.4B£60.98 1.63% up 85% up United States
9Twist BioscienceTWST · Health Care9.0£6.1B£90.00 5.72% up 340% up United States
10ExelixisEXEL · Health Care9.2£12.8B£52.46 0.76% up 63% up United States
11ImmunovantIMVT · Health Care10.5£5.3B£25.44 0.78% up 43% up United States
12ModernaMRNA · Health Care11.8£61.4B£151.82 3.42% down 755% up United States
13Revolution MedicinesRVMD · Health Care14.5£26.4B£122.05 1.30% down 131% up United States
14Gilead SciencesGILD · Health Care16.1£159.3B£128.47 0.73% down 33% up United States
15AmgenAMGN · Health Care16.8£183.5B£339.31 2.52% down 34% up United States
16Adaptive BiotechnologiesADPT · Health Care26.4£3.5B£21.89 1.07% up 88% up United States
17Scholar Rock HoldingSRRK · Health Care34.4£4.4B£36.16 5.52% up 14% up United States
18Kodiak SciencesKOD · Health Care493£4.8B£73.52 0.08% down 396% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7601 GBP). 6 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech companies have the lowest P/B ratio?

Biogen (2.0), Vaxcyte (3.5) and Neurocrine Biosciences (4.3) have the lowest P/B ratio of the 18 biotech companies ranked here as of 18 Nov 2026, 18:41 UTC.

How many biotech companies are in this ranking?

18 are ranked by P/B ratio. 6 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 18 biotech companies ranked by P/B ratio have a combined market value of £639B as of 18 Nov 2026, 18:41 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech companies by P/B ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.